Redcare Pharmacy NV (ETR:RDC)

Germany flag Germany · Delayed Price · Currency is EUR
45.28
+0.70 (1.57%)
May 25, 2026, 5:35 PM CET
Market Cap910.65M -64.2%
Revenue (ttm)3.07B +21.6%
Net Income-37.40M
EPSn/a
Shares Out20.11M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,596
Average Volume122,783
Open45.20
Previous Close44.58
Day's Range45.02 - 45.52
52-Week Range30.20 - 130.10
Beta1.45
RSI47.11
Earnings DateMay 6, 2026

About Redcare Pharmacy NV

Redcare Pharmacy NV operates the online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It offers prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is based in Sevenum, the Netherlands. [Read more]

Sector Healthcare
Founded 2001
Employees 2,163
Stock Exchange Deutsche Börse Xetra
Ticker Symbol RDC
Full Company Profile

Financial Performance

In 2025, Redcare Pharmacy NV's revenue was 2.94 billion, an increase of 24.06% compared to the previous year's 2.37 billion. Losses were -37.70 million, -17.14% less than in 2024.

Financial Statements

News

Redcare Pharmacy NV Earnings Call Transcript: Q1 2026

Q1 2026 saw 18% revenue growth to €849M, with strong Rx and non-Rx performance, improved EBITDA margin, and a rebound in German non-Rx. Guidance remains unchanged amid regulatory uncertainty and early-year volatility, with continued investment in IT and marketing optimization.

19 days ago - Transcripts

Redcare Pharmacy NV Slides: Q1 2026

Redcare Pharmacy NV has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.

19 days ago - Filings

Redcare Pharmacy NV Quarterly report: Q1 2026

Redcare Pharmacy NV has published its Q1 2026 quarterly earnings report on May 6, 2026.

19 days ago - Filings

Redcare Pharmacy NV Earnings release: Q1 2026

Redcare Pharmacy NV released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.

19 days ago - Filings

Redcare Pharmacy NV Earnings Call Transcript: Q1 2026

Q1 2026 saw 18% revenue growth to €849M, with strong Rx and non-Rx performance, improved EBITDA margin, and a rebound in German non-Rx. Guidance remains unchanged amid regulatory uncertainty and early-year volatility, with continued investment in IT and marketing optimization.

19 days ago - Transcripts

Redcare Pharmacy NV Slides: Q1 2026

Redcare Pharmacy NV has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.

19 days ago - Filings

Redcare Pharmacy NV Quarterly report: Q1 2026

Redcare Pharmacy NV has published its Q1 2026 quarterly earnings report on May 6, 2026.

19 days ago - Filings

Redcare Pharmacy NV Earnings release: Q1 2026

Redcare Pharmacy NV released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.

19 days ago - Filings

Redcare Pharmacy NV Earnings Call Transcript: Q1 2026

Q1 2026 saw 18% revenue growth to €849M, with strong Rx and non-Rx performance, improved EBITDA margin, and a rebound in German non-Rx. Guidance remains unchanged amid regulatory uncertainty and early-year volatility, with continued investment in IT and marketing optimization.

19 days ago - Transcripts

Redcare Pharmacy NV Slides: Q1 2026

Redcare Pharmacy NV has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.

19 days ago - Filings

Redcare Pharmacy NV Quarterly report: Q1 2026

Redcare Pharmacy NV has published its Q1 2026 quarterly earnings report on May 6, 2026.

19 days ago - Filings

Redcare Pharmacy NV Earnings release: Q1 2026

Redcare Pharmacy NV released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.

19 days ago - Filings

Redcare Pharmacy NV Earnings Call Transcript: Q4 2025

Full-year revenues rose 24% to EUR 2.9 billion, driven by strong Rx growth and logistics expansion. 2026 guidance targets 13%-15% sales growth, Rx Germany revenues above EUR 670 million, and an adjusted EBITDA margin of at least 2.5%.

2 months ago - Transcripts

Redcare Pharmacy NV Earnings release: Q4 2025

Redcare Pharmacy NV released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.

2 months ago - Filings

Redcare Pharmacy NV Annual report: Q4 2025

Redcare Pharmacy NV has published its Q4 2025 annual report on March 4, 2026.

2 months ago - Filings

Redcare Pharmacy NV Slides: Q4 2025

Redcare Pharmacy NV has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.

2 months ago - Filings

Redcare Pharmacy NV Earnings Call Transcript: Q4 2025

Full-year revenues rose 24% to EUR 2.9 billion, driven by strong Rx growth and logistics expansion. 2026 guidance targets 13%-15% sales growth, Rx Germany revenues above EUR 670 million, and an adjusted EBITDA margin of at least 2.5%.

2 months ago - Transcripts

Redcare Pharmacy NV Earnings release: Q4 2025

Redcare Pharmacy NV released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.

2 months ago - Filings

Redcare Pharmacy NV Annual report: Q4 2025

Redcare Pharmacy NV has published its Q4 2025 annual report on March 4, 2026.

2 months ago - Filings

Redcare Pharmacy NV Slides: Q4 2025

Redcare Pharmacy NV has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.

2 months ago - Filings

Redcare Pharmacy NV Earnings Call Transcript: Q4 2025

Full-year revenues rose 24% to EUR 2.9 billion, driven by strong Rx growth and logistics expansion. 2026 guidance targets 13%-15% sales growth, Rx Germany revenues above EUR 670 million, and an adjusted EBITDA margin of at least 2.5%.

2 months ago - Transcripts

Redcare Pharmacy NV Earnings release: Q4 2025

Redcare Pharmacy NV released its Q4 2025 earnings on March 4, 2026, summarizing the period's financial results.

2 months ago - Filings

Redcare Pharmacy NV Annual report: Q4 2025

Redcare Pharmacy NV has published its Q4 2025 annual report on March 4, 2026.

2 months ago - Filings

Redcare Pharmacy NV Slides: Q4 2025

Redcare Pharmacy NV has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 4, 2026.

2 months ago - Filings

German online drug retailer Redcare Pharmacy names Hendrik Krampe as CFO

German online drug retailer Redcare Pharmacy on Monday named Hendrik Krampe as its chief financial officer, effective December 1.

7 months ago - Reuters